Danyelza
(naxitamab)DANYELZA 40 MG in 10 ML Injection
Dosage & administration
The recommended dosage of DANYELZA is 3 mg/kg/day (up to 150 mg/day), administered as an intravenous infusion after dilution on Days 1, 3, and 5 of each treatment cycle. Treatment cycles are repeated every 4 weeks until complete response or partial response, followed by 5 additional cycles every 4 weeks. Subsequent cycles may be repeated every 8 weeks.
Discontinue DANYELZA and GM-CSF for disease progression or unacceptable toxicity. Administer GM-CSF subcutaneously prior to and during each treatment cycle as recommended.
drug label
Danyelza prescribing information
prior authorization
Danyelza prior authorization resources
Most recent Danyelza prior authorization forms
View By PayerVerified: Apr 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington
Verified: Apr 01, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form
Verified: Apr 01, 2024Highmark BCBS Northeastern NY - Short Acting Opioid Prior Authorization Form
Verified: Apr 01, 2024Highmark BCBS Western NY - Specialty Drug Prior Authorization Form
Verified: Apr 01, 2024Highmark BCBS Western NY - Non-Formulary Drug Coverage Prior Authorization Form
Most recent state uniform prior authorization forms
Verified: Mar 28, 2024Arizona - Uniform Prior Authorization Form
Verified: Mar 28, 2024Colorado - Uniform Prior Authorization Form
Verified: Mar 28, 2024Hawaii - Uniform Prior Authorization Form
Verified: Mar 28, 2024Illinois - Uniform Prior Authorization Form
Verified: Mar 28, 2024Indiana - Uniform Prior Authorization Form
Verified: Mar 28, 2024Louisiana - Uniform Prior Authorization Form
Verified: Mar 28, 2024Minnesota - Uniform Prior Authorization Form
Verified: Mar 28, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Mar 28, 2024New Mexico - Uniform Prior Authorization Form
Verified: Mar 28, 2024Oregon - Uniform Prior Authorization Form
Verified: Mar 28, 2024Texas - Uniform Prior Authorization Form
Learn More
If available, these templates are provided by the brand to help you navigate insurance, especially with newer drugs.
Benefits investigation
Learn More
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
Learn More
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
financial assistance
Danyelza financial assistance options
Co-pay savings program
commercial only
Learn More
Overview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Foundation programs
under insured
no insurance
goverment insurance
65+
Learn More
Overview
- Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
- These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
- Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
- Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
- Patients submit proof of out-of-pocket drug costs to charities for reimbursement
PubMed™ | Danyelza
Danyelza PubMed™ News
patient education
Danyelza patient education
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Receiving Danyelza & Preparing For Treatment
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
Other resources
Learn More
Other resources brands publish to help support patients.
people also ask
Danyelza FAQs
How is the dosage of Danyelza?Danyelza is available in 1 dosages, including 4 mg/ml Injection 10 ml
What does Danyelza treat?Danyelza treats Neuroblastoma
How Is Danyelza Administered?Danyelza is administered as a Injectable
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available